Implantica AG engages in the provision of effective care for serious health conditions and improving patient quality of life by bringing advanced technology into the body. Its product RefluxStop, is a passive CE-marked implant for prevention of gastroesophageal reflux. The company was founded by Peter Forsell in 2015 and is headquartered in Vaduz, Liechtenstein.
Die Digitalisierung ist im Gesundheitswesen angekommen. Nicht umsonst ist der Bereich Electronic Health (eHealth) inzwischen der am schnellsten wachsende Behandlungsbereich der Welt.
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces that on 23 December 2024 the company executed a directed...
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of...
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of...
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, is pleased to report an impressive level of support from a large...
